Your browser doesn't support javascript.
loading
Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV.
Chambers, Catharine; Samji, Hasina; Cooper, Curtis L; Costiniuk, Cecilia T; Janjua, Naveed Z; Kroch, Abigail E; Arbess, Gordon; Benoit, Anita C; Buchan, Sarah A; Chung, Hannah; Kendall, Claire E; Kwong, Jeffrey C; Langlois, Marc-André; Lee, Samantha M; Mbuagbaw, Lawrence; McCullagh, John; Moineddin, Rahim; Nambiar, Devan; Walmsley, Sharon; Anis, Aslam H; Burchell, Ann N.
Afiliação
  • Chambers C; Dalla Lana School of Public Health, University of Toronto.
  • Samji H; Unity Health Toronto, Toronto, ON.
  • Cooper CL; British Columbia Centre for Disease Control, Vancouver.
  • Costiniuk CT; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC.
  • Janjua NZ; Ottawa Hospital Research Institute, Ottawa, ON.
  • Kroch AE; Research Institute of the McGill University Health Centre, Montreal, QC.
  • Arbess G; British Columbia Centre for Disease Control, Vancouver.
  • Benoit AC; School of Population and Public Health, University of British Columbia.
  • Buchan SA; Canadian HIV Trials Network, Vancouver, BC.
  • Chung H; Dalla Lana School of Public Health, University of Toronto.
  • Kendall CE; Ontario HIV Treatment Network.
  • Kwong JC; Public Health Ontario.
  • Langlois MA; Unity Health Toronto, Toronto, ON.
  • Lee SM; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto.
  • Mbuagbaw L; Dalla Lana School of Public Health, University of Toronto.
  • McCullagh J; Department of Health and Society, University of Toronto Scarborough, Scarborough.
  • Moineddin R; Women's College Research Institute, Women's College Hospital.
  • Nambiar D; Dalla Lana School of Public Health, University of Toronto.
  • Walmsley S; Public Health Ontario.
  • Anis AH; ICES (formerly Institute for Clinical Evaluative Sciences).
  • Burchell AN; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto.
AIDS ; 36(15): F17-F26, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36254892
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Infecções por HIV / Influenza Humana / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Revista: AIDS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Infecções por HIV / Influenza Humana / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Revista: AIDS Ano de publicação: 2022 Tipo de documento: Article